DTIL
Price
$4.63
Change
+$0.10 (+2.21%)
Updated
Jul 17, 01:47 PM (EDT)
Capitalization
50.12M
IVEVF
Price
$2.28
Change
-$1.36 (-37.36%)
Updated
Feb 12 closing price
Capitalization
447.8M
Interact to see
Advertisement

DTIL vs IVEVF

Header iconDTIL vs IVEVF Comparison
Open Charts DTIL vs IVEVFBanner chart's image
Precision BioSciences
Price$4.63
Change+$0.10 (+2.21%)
Volume$500
Capitalization50.12M
INVENTIVA SA
Price$2.28
Change-$1.36 (-37.36%)
Volume$1K
Capitalization447.8M
DTIL vs IVEVF Comparison Chart in %
Loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTIL vs. IVEVF commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a Hold and IVEVF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (DTIL: $4.52 vs. IVEVF: $2.28)
Brand notoriety: DTIL and IVEVF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 109% vs. IVEVF: 100%
Market capitalization -- DTIL: $50.12M vs. IVEVF: $447.8M
DTIL [@Biotechnology] is valued at $50.12M. IVEVF’s [@Biotechnology] market capitalization is $447.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $300.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 1 FA rating(s) are green whileIVEVF’s FA Score has 0 green FA rating(s).

  • DTIL’s FA Score: 1 green, 4 red.
  • IVEVF’s FA Score: 0 green, 5 red.
According to our system of comparison, both DTIL and IVEVF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 5 TA indicator(s) are bullish.

  • DTIL’s TA Score: 5 bullish, 5 bearish.

Price Growth

DTIL (@Biotechnology) experienced а -4.44% price change this week, while IVEVF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.68%. For the same industry, the average monthly price growth was +13.20%, and the average quarterly price growth was +38.06%.

Reported Earning Dates

DTIL is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+1.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVEVF($448M) has a higher market cap than DTIL($50.1M). DTIL YTD gains are higher at: 18.635 vs. IVEVF (-37.363).
DTILIVEVFDTIL / IVEVF
Capitalization50.1M448M11%
EBITDA-16.57MN/A-
Gain YTD18.635-37.363-50%
P/E Ratio4.53N/A-
Revenue51.1MN/A-
Total Cash77.2MN/A-
Total Debt29.7MN/A-
FUNDAMENTALS RATINGS
DTIL: Fundamental Ratings
DTIL
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DTILIVEVF
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
13%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
13%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRLIX23.70N/A
N/A
Nuveen Large Cap Value R6
ATEYX166.69N/A
N/A
AB Sustainable Global Thematic Advisor
VNSAX22.95N/A
N/A
Natixis Vaughan Nelson Select A
BUIDX33.01N/A
N/A
Buffalo Growth & Income Inst
FEOPX17.39N/A
N/A
Fidelity Enduring Opportunities

IVEVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVEVF has been loosely correlated with VERV. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if IVEVF jumps, then VERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVEVF
1D Price
Change %
IVEVF100%
N/A
VERV - IVEVF
46%
Loosely correlated
N/A
DTIL - IVEVF
32%
Poorly correlated
+1.57%
MIST - IVEVF
28%
Poorly correlated
+12.84%
IDRSF - IVEVF
21%
Poorly correlated
N/A
INTI - IVEVF
17%
Poorly correlated
N/A
More